antviral/hemorrhage

BACKGROUND OF THE INVENTION 1. Field of the Invention The present invention relates to novel, broad-spectrum, antiviral peptides, compositions containing one or more of these, and their use for the prophylactic treatment against and/or therapeutic treatment of infection by hemorrhagic fever viruses

TECHNICAL FIELD The present invention relates to 1,3-Dioxoindene derivatives, pharmaceutically acceptable salts thereof or enantiomers thereof, preparation methods thereof, and pharmaceutical compositions for the prevention and treatment of viral diseases, comprising the same. BACKGROUND

TECHNICAL FIELD The present invention relates to 1,3-Dioxoindene derivatives, pharmaceutically acceptable salts thereof or enantiomers thereof, preparation methods thereof, and pharmaceutical compositions for the prevention and treatment of viral diseases, comprising the same. BACKGROUND

FIELD OF THE INVENTION This invention relates to the use of benzimidazole derivatives and analogs, as well as compositions containing the same, for the treatment or prophylaxis of viral diseases associated with the arenavirus family such as Lassa fever, Argentine hemorrhagic fever, Bolivian

FIELD OF THE INVENTION This invention relates to the use of benzimidaziole derivatives and analogs, as well as compositions containing the same, for the treatment or prophylaxis of viral diseases associated with the arenavirus family such as Lassa fever, Argentine hemorrhagic fever, Bolivian

FIELD OF THE INVENTION This invention relates to the use of benzimidazole derivatives and analogs, as well as compositions containing the same, for the treatment or prophylaxis of viral diseases associated with the arenavirus family such as Lassa fever, Argentine hemorrhagic fever, Bolivian

FIELD OF THE INVENTION This invention relates to the use of benzimidazole derivatives and analogs, as well as compositions containing the same, for the treatment or prophylaxis of viral diseases associated with the arenavirus family such as Lassa fever, Argentine hemorrhagic fever, Bolivian

FIELD OF THE INVENTION This invention relates to the use of benzimidazole derivatives and analogs, as well as compositions containing the same, for the treatment or prophylaxis of viral diseases associated with the arenavirus family such as Lassa fever, Argentine hemorrhagic fever, Bolivian

FIELD OF THE INVENTION The use of benzimidazole derivatives and analogs, as well as compositions containing the same, for the treatment or prophylaxis of viral diseases associated with the arenavirus family such as Lassa fever, Argentine hemorrhagic fever, Bolivian hemorrhagic fever, and Venezuelan

FIELD This invention relates to the use of cycloalkanecarboxylic acid hydrazide derivatives and analogs, as well as compositions containing the same, for the treatment or prophylaxis of viral diseases associated with the arenavirus family such as Lassa fever, Argentine hemorrhagic fever, Bolivian

FIELD This invention relates to the use of cycloalkanecarboxylic acid hydrazide derivatives and analogs, as well as compositions containing the same, for the treatment or prophylaxis of viral diseases associated with the arenavirus family such as Lassa fever, Argentine hemorrhagic fever, Bolivian

FIELD This invention relates to the use of cycloalkanecarboxylic acid hydrazide derivatives and analogs, as well as compositions containing the same, for the treatment or prophylaxis of viral diseases associated with the arenavirus family such as Lassa fever, Argentine hemorrhagic fever, Bolivian

FIELD The use of benzimidazole derivatives and analogs, as well as compositions containing the same, for the treatment or prophylaxis of viral diseases associated with the arenavirus family such as Lassa fever, Argentine hemorrhagic fever, Bolivian hemorrhagic fever, and Venezuelan hemorrhagic

BACKGROUND 1. Technical Field Text The present invention relates to novel compounds, pharmaceutically acceptable salts or optical isomers thereof, methods for preparing the same, and pharmaceutical compositions for prevention or treatment of viral diseases containing the same as active

TECHNICAL FIELD The present invention relates to novel compounds, pharmaceutically acceptable salts or optical isomers thereof, methods for preparing the same, and pharmaceutical compositions for prevention or treatment of viral diseases containing the same as active ingredients. BACKGROUND